Navigation Links
Lupus Foundation of America Accepting Letters of Intent for Research Grants on Adult Stem Cell Research and Health-Related Quality of Life in Pediatric Lupus
Date:7/8/2009

WASHINGTON, July 8 /PRNewswire-USNewswire/ -- The Lupus Foundation of America, Inc. (LFA) is accepting letters of intent until July 13 for grants to advance adult stem cell transplantation research in humans as a treatment for lupus, and to better understand pediatric lupus features and societal factors that affect the health-related quality of life of children, adolescents and young adults with systemic lupus.

The LFA will award one $100,000 grant for adult stem cell research. Both basic and clinical research applications will be accepted. Applications will be judged on the basis of their innovation and potential impact on understanding the role of adult stem cells on the pathophysiology and treatment of systemic lupus.

The LFA also will award one $70,000 grant for health-related quality of life research for pediatric lupus. Projects should address one or more of the following areas: development and validation of tools to measure quality of life in pediatric lupus, understanding of the impact of pediatric lupus on quality of life, determination of risk factors, development and testing of clinical interventions, and studying the impact of age, gender, race and or ethnicity on the various aspects of quality of life in pediatric lupus.

Both grants have the potential for second year funding. Full applications are due August 7 and the grants are to be awarded by September 18.

The LFA utilizes an electronic grants submission process. All interested grant applicants must submit LOI's and full application packages through proposalCENTRAL: https://proposalcentral.altum.com/. Applicants are encouraged to register and complete a professional profile at proposalCENTRAL as soon as possible. Applicants should ensure that their grants and contracts office has registered their institution and signing officials with proposalCENTRAL.

A proposalCENTRAL helpline is available for questions from applicants during normal business hours (8:30 a.m. - 5:00 p.m.), Monday-Friday, EDT. Phone: 1-800-875-2562 x227 (toll free) or 301-916-4557 x227, E-mail: pcsupport@altum.com.

For additional information, prospective applicants may contact:

    Trish Davidson, MPA
    Director of Education and Research
    Lupus Foundation of America
    2000 L. Street, N.W., Suite 710
    Washington, DC  20036
    davidson@lupus.org
    202.349.1164 (phone)
    202.349.1156 (fax)

The Lupus Foundation of America, Inc. (LFA) is the foremost national nonprofit organization dedicated to finding the causes of and cure for lupus and providing services to people affected by lupus.


'/>"/>
SOURCE Lupus Foundation of America
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lupus Foundation of America Seeks Proposals for Research Studies on Childhood Lupus and Stem Cell Transplantation
2. Anxiety and depression lower quality of life in majority of systemic lupus erythematosus patients
3. Novel DNA vaccine leads to kidney damage prevention in systemic lupus erythematosus models
4. Walk for Lupus Now(TM) at the Orange County Great Park
5. Mary Wilson Brings the Crowd to Their Feet at the Sixth Annual Lupus Foundation of America Awards Gala
6. EHE International and the S.L.E. Lupus Foundation Celebrate Lupus Awareness Month in Rockefeller Plaza
7. Decrease in sense of smell seen in lupus patients
8. Father Breaks Cycling Record To Honor Daughters Fight Against Lupus
9. LFAGW to Offer Free Lupus Symposium on May 16 for Patients and Families
10. Birth Control Pills Linked to Lupus Risk
11. Oral contraceptives associated with increased risk of lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... HealthPostures, expert ... Core benefits and advantages built into the home office sit stand solution are ... feel. Ability to gain the benefits embedded in the TaskMate Go are available ...
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. Ronald E. Hawkins, vice ... appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as the new ... 10. Dr. Bell comes to Liberty from the Ohio University Heritage College of ...
(Date:2/24/2017)... ... ... The narrative in “ Signal 8: An Australian Paramedic’s Story ” (published by ... Schanssema describes the tragedies he saw, as well as his struggles with grief and ... unsure of the career path he wanted to take, found fulfillment in a career ...
(Date:2/24/2017)... ... ... Indiana Fiber Network (IFN) President and CEO Kelly C. Dyer recently announced ... the Chairman of the Management Committee when IFN was originally formed in 2002 where ... investor/owners and development of the business plan. He became the first paid employee ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the most award-winning ... Gran Fondo of Marin. For the second year in a row, cyclists will ... , “We are thrilled to provide our safe, non-toxic sunscreen to over 2,000 ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 23, 2017 Non-alcoholic ... on the various drugs being developed for ... all the drugs that are in various ... The pipeline focuses on novel pharmacologic drugs ... stem cell therapies, recombinant proteins and RNA-based ...
(Date:2/24/2017)... -- Xynomic Pharmaceuticals, Inc., an oncology drug research and ... exclusive worldwide rights to develop, manufacture and commercialize ... hematological and solid tumors. To date ... clinical trials of Abexinostat in US, EU and ... completed, demonstrating that Abexinostat is clinically active in ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The latest research Autism Spectrum Disorder Drugs Price Analysis ... the global Autism Spectrum Disorder market. The research answers the ... drugs marketed for Autism Spectrum Disorder and their clinical attributes? How ...
Breaking Medicine Technology: